Trial intelligence / Profile preview

Comparison of Curcumin and Nystatin for denture-associated fungal infection

IRCT20200519047516N1Phase 3Completed

Sponsor
Islamic Azad University
Start
Oct 2020
Modality
Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin and nystatin in denture stomatitis (DS) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Antifungal efficacy. Started Oct 2020; status: completed.

02

Drugs

curcuminnystatin
03

Conditions

denture stomatitis (DS)

Beyond the preview

Go deeper on IRCT20200519047516N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20200519047516N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call